Japan
Japan's pharmaceutical growth hampered by pricing pressures: Fitch Solutions
Japan's pharmaceutical growth hampered by pricing pressures: Fitch Solutions
Sales are expected to fall 30% to US$62b by 2025 once the new annual price review takes effect.
Malaysia's Sime Darby eyes healthcare portfolio expansion
It targets to go beyond other markets within the region.
Japan banks on big data solutions to keep healthcare costs in check
It eyes to employ AI and robots at long-term care facilities to help caregivers.
Japan's healthcare analytics market to boom as ageing population soars
Better tech adoption will stimulate business growth.
Japan's healthcare expenditure hits all-time high of $36b in 2017
This is due to demand for costly anti-cancer drugs.
Japan to build AI hospitals amidst doctor shortage
It could gear up manufacturers to develop more advanced equipment.
Japan eyes record budget to boost welfare spending
But the retirement age may soon be raised.
Japan to remain Asia-Pacific's most attractive pharmaceuticals market
Despite a pricing regime that limits revenue-generation opportunities for companies.
Most Read
1. Asian medical device markets face cost shocks amidst Iran conflict 2. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 3. HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung 4. Global dental articulators market to reach $227.8m by 2030 5. AJJ Medtech hits $8m order book with $3m green supply dealResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation